Global Tumour Ablation Market will be worth USD 2.9 billion by 2022 – New market reports by Data Bridge Market Research

Global Coronary Stents Market is expected to grow at 8.2% in the forecast period 2016 to 2022
Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2022

Global Tumour Ablation Market is expected to reach USD 2.9 billion by 2022, from USD 1.7 billion in 2015 growing at a CAGR of 8.2% during the forecast period of 2016 to 2022.

Global Tumour Ablation Market is segmented based on product types, product types, cancer types, end-user and geography.

For Sample Report: http://databridgemarketresearch.com/reports/global-tumour-ablation-market/

On the basis of type, the global tumour ablation market is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation.

Based on cancer types the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, others.

To read more about the scope and findings of this report visit: http://databridgemarketresearch.com/tumour-ablation-market-reach-usd-2-9/

On the basis of end-user the global tumour ablation market is segmented into hospitals, oncology clinics and others.

Based on geography, the market report covers data for 5 regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report includes market shares of tumor ablation market for global, Europe, North America, Asia Pacific and Rest of the World.

Global players operating in this market are players operating in this market are Galil Medical, Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, Inc., BVM Medical Limited, AngioDynamics, Inc., COMSOL Inc., Boston Scientific Corporation, EDAP TMS S.A. and, HealthTronics, Inc. among other companies.

To Browse Full Report and Pricing: http://databridgemarketresearch.com/reports/global-tumour-ablation-market/

 

Table of Content:

1        INTRODUCTION

        1.1.      OVERVIEW OF THE TUMOUR ABLATION MARKET

        1.2.      MARKET SEGMENTATION & COVERAGE

2        RESEARCH METHODOLOGY

        2.1.      KEY TAKEAWAYS

        2.2.      ARRIVING AT THE TUMOUR ABLATION MARKET SIZE

                   2.2.1. MARKET CRACKDOWN APPROACH 

                   2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                   2.2.3. DATA TRIANGULATION

                   2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                   2.2.5.  KEY DATA POINTS FROM SECONDARY SOURCES

                   2.2.6.  PORTER’S FIVE FORCES MATRIX

                   2.2.7.  PEST ANALYSIS

                   2.2.8.  EPIDEMIOLOGY FORECASTING MODELS

        2.3.      ASSUMPTIONS

3        MARKET LANDSCAPE SUMMARY

4        MARKET OVERVIEW

        4.1.      OVERVIEW

        4.2.      TUMOUR ABLATION MARKET: KEY PRIMARY INSIGHTS

        4.3.      DRIVERS, OPPORTUNITIES AND THREAT ANALYSIS MATRIX

        4.4.      KEY MARKET FINDINGS

        4.5.      KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5        TUMOUR ABLATION MARKET, BY TYPE

        5.1.      OVERVIEW

        5.2.      TUMOUR ABLATION SYSTEMS

                   5.2.1.      RADIO FREQUENCY ABLATION SYSTEM (RFA)

                   5.2.2.      MICROWAVE ABLATION SYSTEM

                   5.2.3.      HIGH FREQUENCY FOCUSED ULTRASOUND ABLATION SYSTEM (HIFU)

                   5.2.4.      LASER ABLATION SYSTEM

                   5.2.5.      CRYOABLATION

        5.3.      IMAGE GUIDANCE PRODUCTS

        5.4.      ACCESSORIES

6        TUMOUR ABLATION MARKET, BY CANCER TYPE

        6.1.      OVERVIEW

        6.2.      LIVER CANCER

        6.3.      BRAIN CANCER

        6.4.      LUNG CANCER

        6.5.      BONE CANCER

        6.6.      KIDNEY CANCER

        6.7.      PANCREATIC CANCER

        6.8.      BREAST CANCER

        6.9.      OTHERS

7        TUMOR ABLATION MARKET, BY END-USER

        7.1.      OVERVIEW

        7.2.      HOSPITALS

        7.3.      ONCOLOGY CLINICS

        7.4.      OTHERS

8        TUMOUR ABLATION MARKET, BY GEOGRAPHY

        8.1.      COUNTRYWISE TUMOUR ABLATION MARKET,   (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN                          THIS CHAPTER BY COUNTRY)

                   8.1.1.      NORTH AMERICA

                                 8.1.1.1.      U.S.

                                 8.1.1.2.      CANADA

                                 8.1.1.3.      MEXICO

                   8.1.2.      EUROPE

                                 8.1.2.1.      GERMANY

                                 8.1.2.2.      FRANCE

                                 8.1.2.3.      U.K.

                                 8.1.2.4.      ITALY

                                 8.1.2.5.      SPAIN

                                 8.1.2.6.      RUSSIA

                                 8.1.2.7.      TURKEY

                                 8.1.2.8.      BELGIUM

                                 8.1.2.9.      NETHERLANDS

                                 8.1.2.10.    SWITZERLAND

                                 8.1.2.11.    REST OF EUROPE

                   8.1.3.      ASIA-PACIFIC (APAC)

                                8.1.3.1.      JAPAN

                                8.1.3.2.      CHINA

                                8.1.3.3.      SOUTH KOREA

                                8.1.3.4.      INDIA

                                8.1.3.5.      AUSTRALIA

                                8.1.3.6.      SINGAPORE

                                8.1.3.7.      THAILAND

                                8.1.3.8.      MALAYSIA

                                8.1.3.9.      REST OF APAC

                   8.1.4.    LATIN AMERICA

                               8.1.4.1.     BRAZIL

                               8.1.4.2.     REST OF LATIN AMERICA

                   8.1.5.    REST OF THE WORLD

        8.2.      KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

9        TUMOUR ABLATION MARKET: COMPETITIVE LANDSCAPE

        9.1.      GLOBAL TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS

        9.2.      NORTH AMERICA TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS

        9.3.      EUROPE TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS

        9.4.      APAC TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS

        9.5.      MERGERS & ACQUISITIONS

        9.6.      NEW PRODUCT DEVELOPMENT & APPROVALS

        9.7.      EXPANSIONS

        9.8.      REGULATORY CHANGES

        9.9.      PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

10      TUMOUR ABLATION MARKET, COMPANY PROFILES

        10.1    MEDTRONIC

                         10.1.1   OVERVIEW

                         10.1.2   SWOT ANALYSIS

                         10.1.3   PRODUCT PORTFOLIO

                         10.1.4   REVENUE ANALYSIS

                         10.1.5   ANALYSTS VIEW

        10.2    GALIL MEDICAL, INC.

                         10.2.1   OVERVIEW

                         10.2.2   SWOT ANALYSIS

                         10.2.3   PRODUCT PORTFOLIO

                         10.2.4   REVENUE ANALYSIS

                         10.2.5   ANALYSTS VIEW

        10.3    PERSEON CORPORATION

                         10.3.1   OVERVIEW

                         10.3.2   SWOT ANALYSIS

                         10.3.3   PRODUCT PORTFOLIO

                         10.3.4   REVENUE ANALYSIS

                         10.3.5   ANALYST VIEW

        10.4    NEUWAVE MEDICAL, INC.

                         10.4.1   OVERVIEW

                         10.4.2   SWOT ANALYSIS

                         10.4.3   PRODUCT PORTFOLIO

                         10.4.4   REVENUE ANALYSIS

                         10.4.5   ANALYSTS VIEW

        10.5    KONINKLIJKE PHILIPS N.V.

                         10.5.1   OVERVIEW

                         10.5.2   SWOT ANALYSIS

                         10.5.3   PRODUCT PORTFOLIO

                         10.5.4   REVENUE ANALYSIS

                         10.5.5   ANALYSTS VIEW

        10.6    INTIO INC.

                         10.6.1   OVERVIEW

                         10.6.2   SWOT ANALYSIS

                         10.6.3   PRODUCT PORTFOLIO

                         10.6.4   REVENUE ANALYSIS

                         10.6.5   ANALYSTS VIEW

        10.7    MERMAID MEDICAL A/S

                         10.7.1   OVERVIEW

                         10.7.2   SWOT ANALYSIS

                         10.7.3   PRODUCT PORTFOLIO

                         10.7.4   REVENUE ANALYSIS

                         10.7.5   ANALYSTS VIEW

        10.8    SONACARE MEDICAL, LLC

                         10.8.1   OVERVIEW

                         10.8.2   SWOT ANALYSIS

                         10.8.3   PRODUCT PORTFOLIO

                         10.8.4   REVENUE ANALYSIS

                         10.1.5   ANALYSTS VIEW

        10.9    DFINE, INC.

                         10.9.1   OVERVIEW

                         10.9.2   SWOT ANALYSIS

                         10.9.3   PRODUCT PORTFOLIO

                         10.9.4   REVENUE ANALYSIS

                         10.9.5   ANALYSTS VIEW

        10.10  MISONIX, INC.

                         10.10.1   OVERVIEW

                         10.10.2   SWOT ANALYSIS

                         10.10.3   PRODUCT PORTFOLIO

                         10.10.4   REVENUE ANALYSIS

                         10.10.5   ANALYSTS VIEW

        10.11  BVM MEDICAL LIMITED

                         10.11.1   OVERVIEW

                         10.11.2   SWOT ANALYSIS

                         10.11.3   PRODUCT PORTFOLIO

                         10.11.4   REVENUE ANALYSIS

                         10.11.5   ANALYSTS VIEW

        10.12  ANGIODYNAMICS, INC.

                         10.12.1   OVERVIEW

                         10.12.2   SWOT ANALYSIS

                         10.12.3   PRODUCT PORTFOLIO

                         10.12.4   REVENUE ANALYSIS

                         10.12.5   ANALYSTS VIEW

        10.13  COMSOL INC.

                         10.13.1   OVERVIEW

                         10.13.2   SWOT ANALYSIS

                         10.13.3   PRODUCT PORTFOLIO

                         10.13.4   REVENUE ANALYSIS

                         10.13.5   ANALYSTS VIEW

        10.14  BOSTON SCIENTIFIC CORPORATION

                         10.14.1   OVERVIEW

                         10.14.2   SWOT ANALYSIS

                         10.14.3   PRODUCT PORTFOLIO

                         10.14.4   REVENUE ANALYSIS

                         10.14.5   ANALYSTS VIEW

       10.15  EDAP TMS S.A.

                         10.15.1   OVERVIEW

                         10.15.2   SWOT ANALYSIS

                         10.15.3   PRODUCT PORTFOLIO

                         10.15.4   REVENUE ANALYSIS

                         10.15.5   ANALYSTS VIEW

       10.16  HEALTHTRONICS, INC.

                         10.16.1   OVERVIEW

                         10.16.2   SWOT ANALYSIS

                         10.16.3   PRODUCT PORTFOLIO

                         10.16.4   REVENUE ANALYSIS

                         10.16.5   ANALYSTS VIEW

11      APPENDIX

        11.1    RELATED REPORTS

        11.2    CUSTOMIZABLE OPTIONS

        11.3    SOURCE SHEET

        11.4    BIBLIOGRAPHY

12      ABOUT DATA BRIDGE MARKET RESEARCH

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Other Reports:

Global Ablation Devices Market – Trends and Forecast to 2022

By Technology (Electrical, Radiation, Radiofrequency, Light, Ultrasound, Cryotherapy, Thermal, Microwave, Hydro-mechanical), By Application (Cancer, Cardiovascular, Orthopedics, Urology, Gynecology, Ophthalmology and Others), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-tumour-ablation-market/